Loading stock data…
$1.06-0.04 (-3.60%)
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
NeuroOne Medical Technologies Corporation in the Healthcare sector is trading at $1.07 with a market capitalization of $14M. Wall Street consensus targets $7.27 (3 analysts), implying a +579.1% move over the next 12 months. The stock is currently near its 52-week low of $0.96, remaining 69.0% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.97M↑ | $1.86M↓ | $2.89M↑ | $2.74M↑ | $1.70M |
| Gross Profit | $1.18M↑ | $990,264↓ | $1.57M↑ | $1.53M↑ | $914,835 |
| Operating Income | -$2.42M↓ | -$2.40M↓ | -$1.71M↓ | -$1.37M↑ | -$1.89M |
| Net Income | -$2.01M↑ | -$2.38M↓ | -$1.44M↑ | -$1.62M↓ | -$1.50M |
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for sp...